Literature DB >> 14700707

Impact of vaccine shortages on immunization programs and providers.

Shannon Stokley1, Jeanne M Santoli, Bayo Willis, Vanda Kelley, Anjella Vargas-Rosales, Lance E Rodewald.   

Abstract

BACKGROUND: During 2001 and the first half of 2002, the United States experienced severe shortages of five of the eight universally recommended vaccines for children.
OBJECTIVES: To evaluate the impact of shortages of diphtheria-tetanus-acellular pertussis vaccine (DTaP), pneumococcal conjugate vaccine (PCV7), and tetanus and diphtheria vaccine (Td) shortages on state and urban area immunization programs and immunization providers between September 2001 and January 2002.
METHODS: (1) Survey of state and urban area immunization program managers. Outcome measures included changes in vaccine distribution and suspension of daycare/Head Start and school entry immunization requirements for Td, DTaP, and PCV7. (2) Interviews with Vaccines for Children Program immunization providers scheduled to receive a routine site visit between January 21 and February 1, 2002. Outcome measures included problems experienced with vaccine orders, implementation of Advisory Committee on Immunization Practices (ACIP) interim recommendations for DTaP and PCV7, and length of time with no DTaP or PCV7 vaccines in stock.
RESULTS: Over 85% of immunization programs changed the way they distributed PCV7, DTaP, and Td vaccines to providers, including limiting the amount of vaccine ordered or distributing partial orders. Additionally, 76% of programs experienced problems purchasing or receiving varicella vaccine. Sixty-eight percent of programs suspended school entry requirements for Td. Immunization providers reported problems with orders of Td (56%), PCV7 (45%), DTaP (30%), and varicella (29%). Approximately 16% and 29% of providers implemented the interim ACIP recommendations for DTaP and PCV7, respectively. However, 21% of providers suspended administration of all doses of PCV7 because they ran out of vaccine before learning of the shortage.
CONCLUSIONS: From suspension of school entry requirements to delaying administration of vaccine, the recent vaccine shortages affected immunization programs' and providers' ability to administer vaccines in a timely manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700707     DOI: 10.1016/j.amepre.2003.09.010

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

1.  Impact of state vaccine financing policy on uptake of heptavalent pneumococcal conjugate vaccine.

Authors:  Shannon Stokley; Kate M Shaw; Lawrence Barker; Jeanne M Santoli; Abigail Shefer
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

2.  Recommended solutions to the barriers to immunization in children and adults.

Authors:  Edwin L Anderson
Journal:  Mo Med       Date:  2014 Jul-Aug

3.  Effect of a national vaccine shortage on vaccine coverage for American Indian/Alaska Native children.

Authors:  Amy V Groom; James E Cheek; Ralph T Bryan
Journal:  Am J Public Health       Date:  2006-02-28       Impact factor: 9.308

4.  Differential effects of the DTaP and MMR vaccine shortages on timeliness of childhood vaccination coverage.

Authors:  Tammy A Santibanez; Jeanne M Santoli; Lawrence E Barker
Journal:  Am J Public Health       Date:  2006-02-28       Impact factor: 9.308

5.  An analysis of the pediatric vaccine supply shortage problem.

Authors:  Sheldon H Jacobson; Edward C Sewell; Ruben A Proano
Journal:  Health Care Manag Sci       Date:  2006-11

6.  Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.

Authors:  Nancy D Lin; Ken Kleinman; K Arnold Chan; Xian-Jie Yu; Eric K France; Feifei Wei; John P Mullooly; Steven Black; David K Shay; Margarette Kolczak; Tracy A Lieu
Journal:  BMC Pediatr       Date:  2006-11-13       Impact factor: 2.125

Review 7.  Immunizations in the United States: a rite of passage.

Authors:  Amanda C Cohn; Karen R Broder; Larry K Pickering
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.